beta2-Adrenergic Agonist class drugs

24 results

  • albuterol sulfate

    (Albuterol Sulfate)
    Sandoz Inc
    Albuterol Sulfate Inhalation Aerosol is indicated for treating or preventing bronchospasm in patients aged 4 years and older with reversible obstructive airway disease and for preventing exercise-induced bronchospasm.
    Medication Details
    Drug Interactions

  • albuterol sulfate

    (Albuterol Sulfate)
    Ritedose Pharmaceuticals, LLC
    Albuterol sulfate inhalation solution is indicated for the relief of bronchospasm in patients aged 2 years and older with reversible obstructive airway disease and for managing acute bronchospasm attacks.
    Medication Details
    Drug Interactions

  • albuterol sulfate

    (Albuterol Sulfate)
    Nephron Pharmaceuticals Corporation
    Albuterol inhalation solution is indicated for the relief of bronchospasm in patients aged 2 years and older with reversible obstructive airway disease and during acute bronchospasm attacks.
    Medication Details
    Drug Interactions

  • albuterol sulfate

    (Albuterol Sulfate)
    Armstrong Pharmaceuticals, Inc.
    Albuterol Sulfate Inhalation Aerosol is indicated for treating or preventing bronchospasm in patients aged 4 and older with reversible obstructive airway disease, as well as for preventing exercise-induced bronchospasm in the same age group.
    Medication Details
    Drug Interactions

  • albuterol sulfate inhalation solution

    (Albuterol Sulfate)
    Ritedose Pharmaceuticals, LLC
    Albuterol Sulfate Inhalation Solution is indicated for relieving bronchospasm in patients aged 2 to 12 years with asthma (reversible obstructive airway disease).
    Medication Details
    Drug Interactions

  • albuterol sulfate inhalation solution, 0.5%

    (Albuterol Sulfate)
    Ritedose Pharmaceuticals, LLC
    Albuterol sulfate inhalation solution is indicated for relieving bronchospasm in patients aged 12 and older with reversible obstructive airway disease and during acute bronchospasm attacks.
    Medication Details
    Drug Interactions

  • anoro ellipta

    (umeclidinium bromide and vilanterol trifenatate)
    GlaxoSmithKline LLC
    ANORO ELLIPTA is indicated for the maintenance treatment of chronic obstructive pulmonary disease (COPD). It is not intended for the relief of acute bronchospasm or asthma treatment, and its safety and effectiveness in asthma have not been established.
    Medication Details
    Drug Interactions

  • arformoterol tartrate

    (Arformoterol tartrate)
    Alembic Pharmaceuticals Inc.
    Arformoterol tartrate inhalation solution is indicated for the long-term, twice daily maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema, via nebulization. It is not intended for acute COPD exacerbations or for treating asthma.
    Medication Details
    Drug Interactions

  • arformoterol tartrate

    (arformoterol tartrate)
    Lifestar Pharma LLC
    Arformoterol tartrate inhalation solution is indicated for the long-term, twice daily maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It is not intended for acute COPD exacerbations or for the treatment of asthma.
    Medication Details
    Drug Interactions

  • arformoterol tartrate

    (arformoterol tartrate)
    NorthStar RxLLC
    Arformoterol tartrate inhalation solution is indicated for long-term maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema, administered via nebulization. It is not intended for acute COPD exacerbations or for asthma treatment.
    Medication Details
    Drug Interactions